Indenoisoquinoline LMP400 for Advanced Solid Tumors and Lymphomas

NCT01794104 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Neoplasm
Lymphoma

Interventions

DRUG: LMP400

Sponsor

National Cancer Institute (NCI)